kala Pharmaceuticals Stock Analysis Long

KALA BIO, Inc.NASDAQ

Descrizione

⋅ 25 ott 2020 09:37

Kala Pharmaceuticals Announces FDA Acceptance of New Drug Application for EYSUVIS™ for Dry Eye Disease
-- FDA Sets PDUFA Goal Date of October 30, 202

The idea is to go long hoping to get the good news from the FDA.

Altro